<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht003821.v1" study_id="phs000733.v1" participant_set="1" date_created="Fri Jul 18 08:20:36 2014"><variable id="phv00201570.v1"><name>SUBJECT_ID</name><description>De-identified subject ID</description><type>string</type></variable><variable id="phv00201571.v1"><name>SEX</name><description>Gender of participant</description><type>integer, encoded value</type><value code="1">Male</value></variable><variable id="phv00201572.v1"><name>AGEPCDX</name><description>Prostate cancer age of diagnosis</description><type>decimal</type><unit>years</unit><logical_min>33</logical_min><logical_max>93</logical_max></variable><variable id="phv00201573.v1"><name>ICPCGAGGRESSIVENESS</name><description>ICPCG Prostate cancer aggressiveness</description><type>string, encoded</type><value code="INSIGNIFICANT">A subject was classified as having had clinically insignificant disease if he had all of the following characteristics:  Clinically unapparent tumor at diagnosis (stage A, NOS, T1a, T1b, or T1c)  Tumor in only one lobe if radical prostatectomy was done (T2a)  No evidence of non-localized disease (node negative NX or N0; no metastasis, M0, confined to prostate, T2a)  Tumor Gleason grade at diagnosis &lt; 6; if no Gleason grade, then not moderately or poorly differentiated  Pretreatment PSA at diagnosis &lt; 4 ng/ml  If deceased, prostate cancer not listed as primary cause of death on death certificate</value><value code="MODERATE">A subject was classified as having had moderate disease if clinical data were available and he did not meet the criteria for insignificant or aggressive disease</value><value code="UNKNOWN">lack of information for classification</value><value code="NA">Not applicable</value></variable><variable id="phv00201574.v1"><name>RACE</name><description>Race of participant</description><type>integer, encoded value, string</type><value code="1">European</value><value code="2">Asian</value><value code="3">African / African American</value><value code="O">other</value><value code="U">Unknown</value></variable><variable id="phv00201575.v1"><name>FAMHX</name><description>Strength of family history of prostate cancer based on number of affected family members</description><type>integer, encoded value</type><value code="1">2 or less affected family members</value><value code="2">3 or more affected family members</value><value code="-9">Control</value></variable><variable id="phv00202311.v1"><name>AFFECTION_STATUS</name><description>Prostate cancer affection status</description><type>integer, encoded value</type><value code="1">Control</value><value code="2">Case</value></variable><variable id="phv00202312.v1"><name>SITEUSE</name><description>ICPCG Institution [AUSTRALIA, CEREPP, FHCRC, FHCRC, FINLAND, GERMANY, ICR, JHU, LSU, MAYO, MICHIGAN, NORTHWESTERN, UTAH]</description><type>string</type></variable></data_table>
